• Behavioral Health
  • Clinical Insights
  • Treatment

Understanding Tardive Dyskinesia: What you need to know

Apr 11th, 2024

Tardive Dyskinesia (TD) – a neurological disorder associated with prolonged use of antipsychotic medications – affects over 600,000 people annually.

Wondering what this means for the people you serve?

Genoa Healthcare recently hosted a webinar to discuss risk factors associated with TD, diagnostic criteria and assessment of TD, and approaches to managing and mitigating the symptoms. The webinar also covered costs and clinical outcomes of treatment options for consumers living with TD.

Watch the recording here:

Let’s talk

Reliable, full-service pharmacy care

Interested in learning more about how Genoa can help support your consumers living with tardive dyskinesia? Contact us today and we’ll be in touch.

"*" indicates required fields

Name*
Does your organization currently partner with Genoa?*
This field is for validation purposes and should be left unchanged.

Recent Posts


  • Art Celebration
  • Consumer Stories
  • People-first Pharmacy Care
Genoa Art Celebration participant heals through art, helps others after losing daughter to substance use disorder

Content warning: This post discusses mental illness and substance use. Please call the Suicide and Crisis Lifeline at 988, the Substance Abuse and Mental Health Services Administration’s National Helpline at...

  • Consumer Stories
  • Partnering with Genoa
  • People-first Pharmacy Care
“It was really emotional”: Genoa pharmacist turned director reunites with consumer

When Jeannie Barrett, PharmD, transitioned from her role as a pharmacist to director of pharmacy operations for Genoa Healthcare, she wondered if she’d get the chance to see her consumers...

  • Clinical Insights
  • Treatment
RELEXXII®: 6 things to know about the new FDA-approved treatment for ADHD

Staying on top of new medication options for your consumers living with ADHD can be difficult. Learn more about the new FDA-approved medication RELEXXII®, a long-acting formulation of methylphenidate. 1....

  • Partnering with Genoa
  • People-first Pharmacy Care
3 reasons to transition your pharmacy to Genoa Healthcare

Having a pharmacy right within your clinic offers a lot of benefits: it can break down barriers to care, improve consumer and provider satisfaction and drive better outcomes for the...